» Articles » PMID: 28607406

Distinct Activation Modes of the Relaxin Family Peptide Receptor 2 in Response to Insulin-like Peptide 3 and Relaxin

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jun 14
PMID 28607406
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Relaxin family peptide receptor 2 (RXFP2) is a GPCR known for its role in reproductive function. It is structurally related to the human relaxin receptor RXFP1 and can be activated by human gene-2 (H2) relaxin as well as its cognate ligand insulin-like peptide 3 (INSL3). Both receptors possess an N-terminal low-density lipoprotein type a (LDLa) module that is necessary for activation and is joined to a leucine-rich repeat domain by a linker. This linker has been shown to be important for H2 relaxin binding and activation of RXFP1 and herein we investigate the role of the equivalent region of RXFP2. We demonstrate that the linker's highly-conserved N-terminal region is essential for activation of RXFP2 in response to both ligands. In contrast, the linker is necessary for H2 relaxin, but not INSL3, binding. Our results highlight the distinct mechanism by which INSL3 activates RXFP2 whereby ligand binding mediates reorientation of the LDLa module by the linker region to activate the RXFP2 transmembrane domains in conjunction with the INSL3 A-chain. In contrast, relaxin activation of RXFP2 involves a more RXFP1-like mechanism involving binding to the LDLa-linker, reorientation of the LDLa module and activation of the transmembrane domains by the LDLa alone.

Citing Articles

Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension.

Zhang S, Larrabee L, Chang A, Desai S, Sloan L, Wang X Sci Rep. 2024; 14(1):13209.

PMID: 38851835 PMC: 11162469. DOI: 10.1038/s41598-024-62804-7.


Expression of Insl3 Protein in Adult .

Donizetti A, Calicchio M, Romano M, Rosati L, Turco M, Carrese A Int J Mol Sci. 2024; 25(10).

PMID: 38791457 PMC: 11122137. DOI: 10.3390/ijms25105419.


Protective Effects of Relaxin 2 (RLXH2) against Hypoxia-Induced Oxidative Damage and Cell Death via Activation of The Nrf2/HO-1 Signalling Pathway in Gastric Cancer Cells.

Wang L, Zhou Y, Lin H, Hou K Cell J. 2023; 25(9):625-632.

PMID: 37718765 PMC: 10520987. DOI: 10.22074/cellj.2023.2000342.1287.


Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2.

Esteban-Lopez M, Wilson K, Myhr C, Kaftanovskaya E, Henderson M, Southall N Commun Biol. 2022; 5(1):1183.

PMID: 36333465 PMC: 9636434. DOI: 10.1038/s42003-022-04143-9.


Diverse functions of insulin-like 3 peptide.

Esteban-Lopez M, Agoulnik A J Endocrinol. 2020; 247(1):R1-R12.

PMID: 32813485 PMC: 7453995. DOI: 10.1530/JOE-20-0168.


References
1.
Kong R, Shilling P, Lobb D, Gooley P, Bathgate R . Membrane receptors: structure and function of the relaxin family peptide receptors. Mol Cell Endocrinol. 2010; 320(1-2):1-15. DOI: 10.1016/j.mce.2010.02.003. View

2.
Haugaard-Kedstrom L, Hossain M, Daly N, Bathgate R, Rinderknecht E, Wade J . Solution structure, aggregation behavior, and flexibility of human relaxin-2. ACS Chem Biol. 2014; 10(3):891-900. DOI: 10.1021/cb500918v. View

3.
Adham I, Burkhardt E, Benahmed M, Engel W . Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem. 1993; 268(35):26668-72. View

4.
Hyberts S, Takeuchi K, Wagner G . Poisson-gap sampling and forward maximum entropy reconstruction for enhancing the resolution and sensitivity of protein NMR data. J Am Chem Soc. 2010; 132(7):2145-7. PMC: 2825045. DOI: 10.1021/ja908004w. View

5.
Wheatley M, Wootten D, Conner M, Simms J, Kendrick R, Logan R . Lifting the lid on GPCRs: the role of extracellular loops. Br J Pharmacol. 2011; 165(6):1688-1703. PMC: 3372823. DOI: 10.1111/j.1476-5381.2011.01629.x. View